Skip to main content
Livermore
Livermore
ZHEN

Conning Inc.

SEC CIK
0000801051
Latest filing
Jul 30, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Conning Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
432
Value
$269.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Conning Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026432$269.4K<0.1%−29−6.3%ReducedHolders
Q1 2026461$356.2K<0.1%−70−13.2%ReducedHolders
Q4 2025531$409.9K<0.1%+11+2.1%AddedHolders
Q3 2025520$292.4K<0.1%00.0%UnchangedHolders
Q2 2025520$273.0K<0.1%−28−5.1%ReducedHolders
Q1 2025548$347.6K<0.1%−3−0.5%ReducedHolders
Q4 2024551$392.5K<0.1%−73−11.7%ReducedHolders
Q3 2024624$656.0K<0.1%−11−1.7%ReducedHolders
Q2 2024635$667.4K<0.1%+16+2.6%AddedHolders
Q1 2024619$595.8K<0.1%+47+8.2%AddedHolders
Q4 2023572$502.4K<0.1%+2+0.4%AddedHolders
Q3 2023570$469.1K<0.1%−9−1.6%ReducedHolders
Q2 2023579$416.0K<0.1%−70−10.8%ReducedHolders
Q1 2023649$533.3K<0.1%−7−1.1%ReducedHolders
Q4 2022656$473.3K<0.1%−4−0.6%ReducedHolders
Q3 2022660$455.0K<0.1%−34−4.9%ReducedHolders
Q2 2022694$410.0K<0.1%−4−0.6%ReducedHolders
Q1 2022698$487.0K<0.1%−114−14.0%ReducedHolders
Q4 2021812$513.0K<0.1%−17−2.1%ReducedHolders
Q3 2021829$502.0K<0.1%−311−27.3%ReducedHolders
Q2 20211,140$637.0K<0.1%−125−9.9%ReducedHolders
Q1 20211,265$599.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.